Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-02-10 @ 12:29 PM
Study NCT ID:
NCT03944356
Status:
COMPLETED
Last Update Posted:
2025-03-12
First Post:
2019-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Sponsor:
EuMelaReg gGmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EUMR-18001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None